Some researchers have reported that ATOH8 may be master regulators in lung adenocarcinoma [28], breast cancer [29], hepatocellular carcinoma [30], and colorectal cancer [31] to promote or inhibit tumor progression. The gene discussed is ATOH8; the disease is breast carcinoma.